Nature Publishing Group

lessfrustratedΒιοτεχνολογία

23 Οκτ 2013 (πριν από 3 χρόνια και 9 μήνες)

70 εμφανίσεις

Nature Publishing Group

Quality, Impact & Vision

1


Presented by

Professor Nick Lemoine, MD PhD

and Publishing Manager, Rebecca Vickerstaff


www.nature.com/gt




How to Get Your Paper Published in
Gene Therapy



2

Nature Publishing Group


Leading scientific publisher



Nature, Nature Research journals,

Nature reviews, NPG academic journals,

Scientific American…



Focus on quality rather than quantity



Serving authors/readers needs



3




At the forefront of medicine,
Gene Therapy

brings you the latest
research into genetic and cell
-
based technologies to treat disease. It
also publishes Progress & Prospects reviews and News and
Commentary articles, which highlight the cutting edge of the field.


Key Facts





A founding journal in a field of great potential



First published in 1994



High profile editors



12 issues a year



Print and online publication



Impact Factor 4.538



Online publication within 26 days

4

To which journal should you send your manuscript?

Questions to ask…



Is your paper within the scope of the journal?


What is the quality of other papers published?


How easy is electronic submission?


How quickly will you receive a decision?


How quickly will your paper be published?


Does the journal offer an ‘open access’ option?


Does the journal reach an appropriate audience?


5

How much should you worry about Impact Factors?


Impact Factors are important and are currently the predominant
method used to rank journals in terms of quality



Calculated as the number of cites received in the impact factor
year to articles published in the previous 2 years



Gene Therapy
’s 2010 Impact Factor released in June 2011 =
4.538



Obviously there are journals with higher IF than
Gene Therapy

eg.
Nature Medicine

(25.430) or
Nature Biotechnology

(31.085)



Equally important to think about scope, ease of publication, reach,
promotion and service delivered to you by the Publisher




6

Journal scope and content


Gene Therapy

covers both the research and clinical applications of the
new genetic therapy techniques currently being developed. Over the last
decade, gene therapy protocols have entered clinical trials in increasing
numbers and as they cover a wide spectrum of diseases, these studies
promise to unite the diverse organ
-
based specialities into which modern
medicine has become divided.
Gene Therapy

covers all aspects of gene
therapy as applied to human disease, including:



novel technological developments for gene transfer, control and silencing


basic science studies of mechanisms of gene transfer and control of
expression


preclinical animal model systems and validation studies


clinical trial reports which have significant impact for the field


gene
-
based vaccine development and applications


cell
-
based therapies including all aspects of stem cells and genetically
modified cellular approaches

7

Reviews


Review articles in
Gene Therapy

aim to provide accessible,
authoritative overviews of a field or topic.



Reviews should communicate a sense of enthusiasm, weaving
background information with the latest advances, and placing
both of these elements in the context of the rest of the field.



The abstract describes what the article is about in a succinct,
easily digestible way. It should not contain specialist details,
abbreviations, references or figure citations.



References should concentrate on significant original research
papers.


8


Novel or original findings



Credibility


Brevity


Clarity of data and conclusions


Interesting to the international community



Good standard of English (seek help if necessary)


Compliance with ethical standards and approval by
Institutional Review Board if appropriate


Disclosure of possible conflicts of interests by all authors


References complete and up
-
to
-
date


What are Editors looking for?

9

Preparing for submission


Read the Instructions to Authors
carefully


Regular manuscripts submitted to the journal follow a
standard format


When ready to submit, ensure that you have available:




-

All authors’ names, postal and e
-
mail addresses




-

The complete manuscript with all images, tables and



figures in the appropriate format




-

Cover letter drawing the editor’s attention to any special


points



At this point you can also choose to ask NPG to deposit the
author’s accepted version into PubMed Central on behalf of all
authors upon publication or have your paper published open
access.


10

Open Access

Gene Therapy

now offers authors open access


option to pay a one
-
off fee

To have your final published version made freely available immediately on

publication rather rely on readers who have paid subscriptions



Fee is £2,500


NPG already complies with major funding agencies but this is a further
step forward


Final version automatically deposited into PubMed Central


Choose one of two creative commons licences


Research receives greater visibility


11 papers published open access in 2011 so far


expected growth year on

year


11

The peer review process


Upon submission your manuscript will be quality
-
checked by the Journal Manuscript


Coordinator and then assigned to the Editors who:



Determine if the manuscript is within the scope of the Journal



Assess whether the paper is of sufficient novelty and quality to be sent out for
review



If NO a rapid reject decision will be made to enable the author to submit
to another journal as quickly as possible



If YES the Editor will ask 2 or more experts to review the manuscript as
rapidly as they can



Based on the reviewers’ reports the Editor will make an initial decision to
accept, to reject or to ask for revision.



The decision letter is sent to the corresponding author


12

Revision of manuscript


If you are asked to revise your manuscript a revision you will have to
submit a revised version within 3 months.


You must include a covering letter indicating exactly how you have
responded to each point raised by the Editor and reviewers.


If you judge the reviewer to be incompetent or not to have understood
your paper, you can explain this clearly in your reply and but preferably
using tactful language!


Upon resubmission your paper may be sent for review again and you
may be asked to carry out further revision.


Acceptance is never guaranteed until you receive the editor’s letter telling
you the paper has been accepted for publication.


If accepted, your paper will be passed on to the NPG production
department.


13

The production process


A production editor will ensure your paper meets
Gene Therapy
’s house
style:


Check punctuation, grammar, and consistency of terminology


Check pharmaceutical names and abbreviations


Check references


Figures and tables are formatted and the manuscript is typeset



Reasons for delays to starting work on a paper:


Artwork in wrong format


Licence To Publish form not complete


Open access payment form not received



Page proofs are e
-
mailed to the corresponding author within 8 weeks of
acceptance


corrections to be made to a .pdf version.



Once paper is returned a Document Object Identifier (DOI) number is
assigned and paper is ‘queued’ for advanced online publication (AOP).


14

Advanced online publication (AOP)


Papers are published online in batches once a week



Your paper should appear online within 26 days of receipt in
production providing you return your proofs in a timely manner.



This is the final published version and can now be cited.



Your paper is recorded in PubMed as soon as it is published
online, ensuring more people see your article over a longer
amount of time.



If you have chosen the open access option your paper will be
freely available for all to view; if not, for one year the full text
version will be available to persons who have paid subscriptions.



Ideally the print version of your paper will appear within 4 months
of acceptance


15

Once published: promotion and visibility


Large subscriber base and high web traffic.



Electronic table of contents (e
-
ToC alerts) with direct links to all newly
published articles are sent to over 100,000 registered users each month.



All articles are included in key abstracting, indexing and linking services
including ISI, PubMed, Medline, Embase and Crossref.



Selected articles are press
-
released.



Selected articles appear on the Nature homepage (www.nature.com), in
web focuses, and on subject area pages, all of which highlight the latest
and best research from across the NPG portfolio.



Articles are included in a range of promotional campaigns


print adverts
/ reprint collections / conference promotion / online promotions / email
campaigns


16

Please submit your article online to
Gene Therapy

www.nature.com/gt



Any Comments or questions?